Twice each month the CEA Registry Blog lists recently published cost utility studies and associated papers. 35 papers were listed this time. Here's a handful in our areas of research interest:
Dinh TA, Alperin P, Walter LC, et al. Impact of Comorbidity on Colorectal Cancer Screening Cost-Effectiveness Study in Diabetic Populations. J Gen Intern Med. 2012 Jan 12. [Epub ahead of print] PubMed PMID: 22237663.
Lippuner K, Johansson H, Borgström F, et al. Cost-effective intervention thresholds against osteoporotic fractures based on FRAX® in Switzerland. Osteoporos Int. 2012 Jan 6. [Epub ahead of print] PubMed PMID: 22222755.
Coleman CI, Straznitskas AD, Sobieraj DM, et al. Cost-Effectiveness of Clopidogrel Plus Aspirin for Stroke Prevention in Patients With Atrial Fibrillation in Whom Warfarin Is Unsuitable. Am J Cardiol. 2012 Jan 3. [Epub ahead of print] PubMed PMID: 22221944.
Hall PS, McCabe C, Stein RC, et al. Economic evaluation of genomic test-directed chemotherapy for early-stage lymph node-positive breast cancer. J Natl Cancer Inst. 2012 Jan 4;104(1):56-66. Epub 2011 Dec 2. PubMed PMID: 22138097.
Retèl VP, Joore MA, van Harten WH. Head-to-head comparison of the 70-gene signature versus the 21-gene assay: cost-effectiveness and the effect of compliance. Breast Cancer Res Treat. 2012 Jan;131(2):627-36. Epub 2011 Sep 24. PubMed PMID: 21947677.
Lavelle TA, Uyeki TM, Prosser LA. Cost-effectiveness of oseltamivir treatment for children with uncomplicated seasonal influenza. J Pediatr. 2012 Jan;160(1):67-73.e6. Epub 2011 Sep 13. PubMed PMID: 21917267.
Yamamoto N, Mori R, Jacklin P, et al. Introducing HPV vaccine and scaling up screening procedures to prevent deaths from cervical cancer in Japan: a cost-effectiveness analysis. BJOG. 2012 an;119(2):177-86Epub 2011 Jul 28. PubMed PMID: 21794070.
